Acetazolamide, carbonic anhydrase inhibitor, was found to inhibit the expression of AQP1, which protected tumor from cytotoxic edema by maintenance of extracellular acidification and promoted tumor metastasis in glioma (215). Here, AQP1 is linked to central nervous system cancer.